Consequently, cisplatin-induced senescence (CIS) in βTrCP1-overexpressing cells leads to a gradual reduction of p21 CIP1, enabling cell cycle progression and increasing DNA damage, which ultimately results in cell death. The gene discussed is CDKN1A; the disease is in situ carcinoma.